Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Inter Parfums, Inc. (IPAR) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Inter Parfums, Inc. (IPAR) - free report >>
Image: Bigstock
Top Ranked Momentum Stocks to Buy for March 15th
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, March 15th:
Inter Parfums, Inc. (IPAR - Free Report) : This fragrances and fragrance related products manufacturer has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 4.4% over the last 60 days.
Inter Parfums, Inc. Price and Consensus
Inter Parfums, Inc. price-consensus-chart | Inter Parfums, Inc. Quote
Inter Parfums' shares gained 9.4% over the last one month more than S&P 500’s gain of 1.4%. The company possesses a Momentum Score of A.
Inter Parfums, Inc. Price
Inter Parfums, Inc. price | Inter Parfums, Inc. Quote
Arcosa, Inc. (ACA - Free Report) : This manufacturer of infrastructure-related products has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.8% over the last 60 days.
Arcosa, Inc. Price and Consensus
Arcosa, Inc. price-consensus-chart | Arcosa, Inc. Quote
Arcosa's shares gained 3.9% over the last one month. The company possesses a Momentum Score of A.
Arcosa, Inc. Price
Arcosa, Inc. price | Arcosa, Inc. Quote
Alpine Immune Sciences, Inc. (ALPN - Free Report) : This developer of protein-based immunotherapies has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.2% over the last 60 days.
Nivalis Therapeutics, Inc. Price and Consensus
Nivalis Therapeutics, Inc. price-consensus-chart | Nivalis Therapeutics, Inc. Quote
Alpine Immune’s shares gained 15.9% over the last one month. The company possesses a Momentum Score of B.
Nivalis Therapeutics, Inc. Price
Nivalis Therapeutics, Inc. price | Nivalis Therapeutics, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Is Your Investment Advisor Fumbling Your Financial Future?
See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.”
Click to get it free >>